Literature DB >> 8101902

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

P Cinque1, M Brytting, L Vago, A Castagna, C Parravicini, N Zanchetta, A D'Arminio Monforte, B Wahren, A Lazzarin, A Linde.   

Abstract

Epstein-Barr virus (EBV) is constantly associated with AIDS-related primary lymphomas of the central nervous system (CNS). To assess whether EBV DNA in cerebrospinal fluid (CSF) could be used as a tumour marker, CSF samples that had been taken within 180 days before death from 85 patients with HIV infection and neurological disorders at necropsy were examined retrospectively by nested polymerase chain reaction (PCR) for EBV. Histologically evident primary CNS lymphomas were found in 17 patients, and EBV was shown in tissue by in-situ hybridisation in 16 of the 16 cases examined. All 17 patients with primary CNS lymphoma had EBV DNA in CSF. EBV DNA was found in CSF from 1 of 68 HIV-infected patients without histologically detectable lymphoma at necropsy. PCR for EBV DNA in CSF was 100% sensitive and 98.5% specific for AIDS-associated primary CNS lymphoma, and may be useful as a diagnostic tumour marker.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101902     DOI: 10.1016/0140-6736(93)92814-a

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Detection of Epstein-Barr virus DNA in plasma from patients with lymphoproliferative disease after allogeneic bone marrow or peripheral blood stem cell transplantation.

Authors:  R Beck; I Westdörp; G Jahn; H Schäfer; L Kanz; H Einsele
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 2.  HIV-associated lymphomas.

Authors:  D J Straus
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

Review 3.  Molecular techniques for clinical diagnostic virology.

Authors:  S J Read; D Burnett; C G Fink
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

4.  Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Rajiv T Erasmus; Tandi E Matsha
Journal:  Metab Brain Dis       Date:  2012-03-10       Impact factor: 3.584

5.  Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory.

Authors:  S J Read; K J Jeffery; C R Bangham
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 6.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

7.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.

Authors:  R F Miller; M A Hall-Craggs; D C Costa; N S Brink; F Scaravilli; S B Lucas; I D Wilkinson; P J Ell; B E Kendall; M J Harrison
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

Review 8.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Primary brain lymphomas after kidney transplantation: an under-recognized problem?

Authors:  Nuria Sola-Valls; Néstor Yesid Rodríguez C; Carola Arcal; Carlos Duran; Federico Oppenheimer; Teresa Ribalta; Armando Lopez-Guillermo; Josep Marí Campistol; Francesc Graus; Fritz Diekmann
Journal:  J Nephrol       Date:  2014-01-28       Impact factor: 3.902

10.  Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease.

Authors:  N S Brink; Y Sharvell; M R Howard; J D Fox; M J Harrison; R F Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.